Canopy Growth Corporation, a company listed in the United States, has received a communication from the Division of Corporation Finance Office of Life Sciences, part of the United States Securities and Exchange Commission (SEC), regarding its Preliminary Proxy Statement on Schedule 14A filed on October 25, 2022. The SEC has completed its review of the filing made by Canopy Growth and has issued a reminder to the company and its management about their responsibility for the accuracy and adequacy of their disclosures. This reminder underscores the importance of corporate transparency and the role of the SEC in overseeing disclosure practices. The communication was addressed to David Klein, the Chief Executive Officer of Canopy Growth Corporation, and was dated February 14, 2024.

Canopy Growth Corporation, a company listed in the United States, has received a communication from the Division of Corporation Finance Office of Life Sciences, part of the United States Securities and Exchange Commission (SEC), regarding its Preliminary Proxy Statement on Schedule 14A filed on October 25, 2022. The SEC has completed its review of the filing made by Canopy Growth and has issued a reminder to the company and its management about their responsibility for the accuracy and adequacy of their disclosures. This reminder underscores the importance of corporate transparency and the role of the SEC in overseeing disclosure practices. The communication was addressed to David Klein, the Chief Executive Officer of Canopy Growth Corporation, and was dated February 14, 2024.